S Lavault, Y Dauvilliers, X Drouot… - Sleep Medicine, 2011 - Elsevier Modafinil was the first line treatment in 96–99% of patients. It produced a similar ESS change in IH patients and in narcolepsy patients (−2.6 ± 5.1 vs. −3 ± 5.1) and a similar benefit as estimated by the patients (6.9 ± 2.7 vs. 6.5 ± 2.5 on a visual analog scale) and clinicians. The ESS ... Cited by 1 - Related articles - All 3 versions
F Han, L Lin, J Li, A Aran, SX Dong, P An… - Sleep, 2011 - ncbi.nlm.nih.gov OBJECTIVE: To retrospectively describe childhood presentations of primary hypersomnia with an emphasis on narcolepsy-cataplexy in a Chinese population. METHODS: A total of 417 children (< 18 years old) successively presenting with complaints of hypersomnia without ... Cited by 1
C Peyron, F Valentin, S Bayard, L Hanriot, C Bedetti… - Sleep Medicine, 2011 - Elsevier Narcolepsy with cataplexy (NC) is a disabling disorder characterized by excessive daytime sleepiness and abnormal rapid eye movement (REM) sleep manifestations, due to a deficient hypocretin/orexin neurotransmission. Melanin concentrating hormone (MCH) neurons ... Related articles - All 2 versions
S Janáčková, J Motte, S Bakchine… - Journal of Child …, 2011 - jcn.sagepub.com Abstract Idiopathic hypersomnia is an uncommon sleep disorder characterized by prolonged sleep time and excessive daytime sleepiness without cataplexy. This study concerned a case of familial occurrence. The proband expressed an idiopathic hypersomnia with long sleep ... Related articles - All 3 versions